Robbinsville, NJ, United States of America

Laykea Tafesse

This inventor holds 91 USPTO granted patents and 12 published patent applications, plus 9 CIPO patents and 33 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D401-12). Top assignees: Purdue Pharma L.p., Shionogi Company Limited, Euro-Celtique S.a.. Active years: 2005-2025.

USPTO Granted Patents = 91 (Patent Applications = 12)

% Patents Active = 92.3

CIPO Patents = 9 (Patent Applications = 1)

EPO Patents = 33 (Patent Applications = 49)

Average Co-Inventor Count = 2.3

ph-index = 16

Forward Citations = 559(Granted Patents)

Forward Citations (Not Self Cited) = 207(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Robinsville, NJ (US) (2005 - 2014)
Robbinsville, NJ (US) (2007 - 2023)

Company Filing History:

Shionogi Company Limited

Purdue Pharma, L.p., USA

patents

5. 3 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Morphinan Derivatives

Indole Derivatives

Isoquinoline Derivatives

Sodium Channel Blockers

TRPV1 Antagonists

Azaspiro Derivatives

Pyrimidines

Dibenzazepine Derivatives

Carboxamide Derivatives

Benzimidazole Derivatives

Spirocyclic Morphinans

Pyridine Compounds

91 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297199 - Morphinan derivatives and use thereof (2025-05-13),

2. 11834447 - Indole derivatives and use thereof (2023-12-05),

3. 11401258 - Isoquinoline derivatives and use thereof (2022-08-02),

4. 11180502 - Azaspiro[4.5]decane derivatives and use thereof (2021-11-23),

5. 10858326 - Oxazoline pseudodimers, pharmaceutical compositions and the use thereof (2020-12-08),

6. 10774050 - Pyrimidines as sodium channel blockers (2020-09-15),

7. 10745402 - Morphinan derivatives and use thereof (2020-08-18),

8. 10738026 - Isoquinoline derivatives and use thereof (2020-08-11),

9. 10730866 - Indole derivatives and use thereof (2020-08-04),

10. 10584110 - TRPV1 antagonists including dihydroxy substituent and uses thereof (2020-03-10),

11. 10550090 - Process for preparing substituted 9,10-dioxo-9,10-dihydroanthrecenes and 6H-anthra[1,9-cd]isoxazol-6-ones (2020-02-04),

12. 10550088 - 6-substituted and 7-substituted morphinan analogs and the use thereof (2020-02-04),

13. 10450308 - TRPV1 antagonists including dihydroxy substituent and uses thereof (2019-10-22),

14. 10435406 - 6,7-cyclicmorphinan derivatives and use thereof (2019-10-08),

15. 10202382 - Azamorphinan derivatives and use thereof (2019-02-12),

As an AI assistant for idiyas.com, here is the article about inventor Laykea Tafesse:

Title: A Closer Look at Inventor Laykea Tafesse from Robbinsville, NJ

Introduction:

In the realm of innovation and patents, Laykea Tafesse stands out as a prolific inventor based in Robbinsville, NJ. With an impressive portfolio of 90 patents to his name, Tafesse has made significant contributions to the field of pharmaceuticals and pain management.

Latest Patents:

Tafesse's recent patents showcase his expertise in developing novel compounds for medical applications. One of his latest inventions involves indole derivatives and their use in treating pain and disorders related to sodium channel blockade. Another patent highlights isoquinoline derivatives and their pharmaceutical benefits in addressing similar health conditions.

Career Highlights:

Throughout his career, Laykea Tafesse has been associated with esteemed companies such as Purdue Pharma L.P. and Shionogi & Company Limited. His innovative spirit and dedication to research have undoubtedly propelled him towards numerous groundbreaking discoveries in the pharmaceutical industry.

Collaborations:

Tafesse's collaborative efforts with talented individuals like Jiangchao Yao and Mark Andrew Youngman have played a crucial role in bringing his inventions to life. By working alongside such skilled coworkers, he has been able to leverage their expertise and insights to enhance his patent portfolio.

Conclusion:

In conclusion, Laykea Tafesse's remarkable journey as an inventor reflects his unwavering commitment to advancing medical science through innovative solutions. With a trail of 90 patents behind him, Tafesse continues to make significant strides in the world of pharmaceuticals, leaving a lasting impact on the field of pain management and beyond.